Companies /Healthcare

Gilead Sciences Inc

NASDAQ: GILD Drug Manufacturers - General
$158.69
▲ $2.65 (+1.70%) today
Markets closed · 8:33pm ET

GILD Coverage Page 46

1:12pm ET
Investing

Gilead, Idenix Slug it Out (GILD, IDIX)

When biotech company Gilead Sciences Inc. (NASDAQ: GILD) made a deal last month to acquire Pharmasett for $11 billion, no thought it would pay off so soon. Especially the folks at Idenix…

Paul Ausick
8:02am ET
Investing

Gilead Snags Top Call From Goldman Sachs (GILD)

Gilead Sciences Inc. (NASDAQ: GILD) is trading higher this Monday on a top research upgrade.  The biotech was raised to the Conviction Buy List by Goldman Sachs.  Its new price target is…

Jon C. Ogg
8:57am ET
Investing

Top Active Trader Alert Stocks (GILD, RIMM, VRUS)

Crude oil is at $96.43, down 1.29% Gold is at $1,766, down 0.74%. Hong Kong’s Hang Seng closed down 1.44% to 18,226. Japan’s Nikkei closed lower by 0.32% to 8,348. The U.S.…

Mike Sauter
7:51am ET
Health and Healthcare

Gilead Paying Up (too much) for Pharmasset (GILD, VRUS)

Gilead Sciences Inc. (NASDAQ: GILD) is trading lower on news that it is spending some $11 billion to buy Pharmasset, Inc. (NASDAQ: VRUS).   What is interesting is that Pharmasset was valued only…

Jon C. Ogg